This educational guide covers altered mental status in adult dialysis patients. It supports assessment; it is not a validated risk score or an adopted local treatment protocol. The interactive sections summarize differentials, medication risks and investigations.
Start with airway, ventilation, circulation and bedside glucose. Treat hypoglycemia immediately, monitor the patient and reassess consciousness. Establish baseline cognition, last known well, dialysis modality, the last completed session and whether symptoms began before, during or after treatment. Missed dialysis is a clue, not a diagnosis. Focal findings, ongoing seizures, respiratory failure or shock need immediate parallel treatment and specialist escalation.
AMS in ESRD & Dialysis Patients
Use the expandable sections below for bedside prompts. More than one process may be present.
Call nephrology early. Suspected uremic encephalopathy or pericarditis, medically resistant acidosis or electrolyte disturbance, and uncontrolled pulmonary edema require urgent assessment for dialysis. Use the clinical syndrome and trajectory; no isolated urea or creatinine value proves the cause of AMS. KDIGO 2024, section 5.4.
In a hemodialysis patient, potassium ≥6.5 mmol/L requires urgent dialysis. Give IV calcium for toxic ECG changes even if dialysis is available; use temporizing potassium-lowering treatment if it is delayed. A normal ECG does not remove the danger. Follow the local emergency regimen, with serial potassium and glucose checks after insulin treatment. UKKA guidance, updated July 2026.
First minutes: find the reversible threat
Examine pupils, respiratory effort, perfusion and focal neurology while obtaining an ECG and blood tests. Check sodium, potassium, bicarbonate, calcium, magnesium, glucose and urea; add a blood gas when acid–base disturbance or hypoventilation is possible. Ask the dialysis team about hypotension, interrupted treatment, access problems and drugs given that day.
Keep structural disease in view. Head injury, anticoagulation, focal deficits, a new severe headache or unexplained persistent AMS lower the threshold for urgent non-contrast head CT. A Taiwan cohort found increased subdural hematoma incidence in hemodialysis patients; that association does not supply an individual probability or a universal imaging rule.
Sudden focal deficits or suspected posterior-circulation stroke warrant immediate stroke-team assessment and appropriate vascular imaging. A normal early non-contrast CT does not exclude ischemic stroke. Dialysis alone should not stop reperfusion assessment: establish recent heparin exposure, anticoagulant use, coagulation results and standard eligibility. AHA/ASA 2026 stroke guideline.
Before or after dialysis: separate the mechanisms
Uremic encephalopathy: inadequate clearance may contribute to progressive inattention, confusion, asterixis, seizures or coma. Missed or ineffective treatment raises suspicion, but these findings are nonspecific. Arrange urgent nephrology assessment while looking for competing causes; improvement after dialysis supports the diagnosis retrospectively. Persistent symptoms require reassessment rather than simply more dialysis.
Dialysis disequilibrium: new headache, vomiting, confusion or seizures during or soon after dialysis, particularly initiation or restarting after a prolonged gap, raises concern. Rapid blood urea reduction can outpace equilibration with the brain, drawing water into brain tissue. This physiological explanation does not establish that every post-dialysis neurological symptom is disequilibrium. Hypoglycemia, hypotension, stroke, hemorrhage, infection and drug effects still need evaluation. Mechanism and dialysis-emergency review.
Alert the dialysis team immediately for neurological deterioration during treatment; stop the session for severe symptoms while stabilizing and urgently involving critical care/nephrology.
Subsequent clearance rate and any cerebral-edema treatment need specialist direction. Do not use hypertonic saline or mannitol automatically for post-dialysis confusion. Prevention evidence is sparse: a 2024 Cochrane review found only two small trials, with low or very low certainty.
Infection: inspect the dialysis access and seek pulmonary, urinary, skin or abdominal sources. Obtain appropriate cultures without delaying indicated antibiotics. Probable/definite sepsis or shock needs prompt empiric treatment and source-control planning, then review cultures and narrow therapy. Tailor fluids to perfusion and congestion with repeated reassessment. Surviving Sepsis Campaign 2026.
In peritoneal dialysis, abdominal pain or cloudy effluent requires prompt renal-team assessment and effluent cell count/culture; start indicated treatment without waiting for results. ISPD peritonitis guidance.
A chronic cognitive disorder does not explain an acute change. Historical “dialysis dementia” should not distract from reversible or time-critical causes.
Medication accumulation: check what changed
Check the actual drug, formulation, dose, timing, recent changes and missed sessions. Ask about nonprescription medicines and exposures. Renal adjustment is drug-specific; dialysis clearance and post-dialysis dosing also matter. Involve pharmacy and toxicology when toxicity is plausible.
- Baclofen: therapeutic dosing can cause severe toxicity in kidney impairment. EXTRIP suggests extracorporeal treatment for associated coma requiring ventilation, but the evidence is very low quality. Watch for withdrawal during recovery, especially with long-term use.
- Gabapentin and pregabalin: reduced renal elimination can prolong sedation and toxicity. Check drug- and dialysis-specific dosing; severe poisoning with kidney impairment and ventilated coma needs urgent toxicology/nephrology discussion. EXTRIP recommendations are based on very low-certainty evidence.
- Cefepime: consider neurotoxicity with confusion, myoclonus, aphasia or seizures, including nonconvulsive status. It can occur despite dose adjustment. Stop implicated cefepime and arrange an appropriate antimicrobial alternative with the treating team. Prescribing information.
- Opioids: morphine and active metabolites can accumulate. For suspected opioid-induced hypoventilation, support ventilation and give titrated naloxone, then monitor for recurrent respiratory depression. Morphine prescribing information.
If opioid analgesia is necessary, parenteral fentanyl still needs cautious titration and respiratory, sedation and blood-pressure monitoring. A blanket percentage dose reduction cannot establish safety. Injection label.
Fentanyl patches are unsuitable for acute pain or opioid-naive patients, and the label advises against use in severe renal impairment. Transdermal label.
Avoid initiating tramadol during undifferentiated AMS: impaired elimination, seizure risk and serotonergic interactions complicate assessment. Tramadol label.
Other exposures may change the dialysis indication. In suspected lithium poisoning, neurological toxicity can justify extracorporeal treatment regardless of the measured level; contact toxicology and nephrology urgently. EXTRIP lithium guidance. Do not generalize one toxin’s dialysis criteria to another.
Review potassium-raising drugs, including trimethoprim-containing antibiotics, and withhold implicated agents during hyperkalemia while arranging indication-specific alternatives. Medication review must not delay treatment.
Reassessment, correction hazards and disposition
Control the osmotic change. Severe neurological symptoms attributable to hyponatremia require prompt monitored hypertonic saline treatment. The immediate goal is a small controlled rise, not normalization. Excess correction risks osmotic demyelination. Agree a sodium target and monitoring plan with nephrology/critical care before dialysis, because dialysis can change sodium as well as urea. Apply a lower correction ceiling when risk factors warrant it. Society for Endocrinology emergency guidance.
With marked hyperglycemia, assess ketones, acid–base status and osmolality for DKA/HHS. Dialysis patients may already be fluid overloaded; routine large-volume fluids and potassium replacement can harm. Coordinate insulin, fluids and dialysis to avoid abrupt osmotic shifts, with close biochemical and clinical reassessment. 2024 hyperglycemic-crisis consensus.
Ongoing unexplained impaired consciousness, especially after a seizure or with myoclonus, warrants urgent neurology assessment and EEG for possible nonconvulsive seizures. A quiet examination does not exclude them. ACNS consensus.
Repeat glucose, neurological examination, vital signs and relevant chemistry after each intervention. Treat severe hypertension with neurological injury through the appropriate emergency pathway; consider hypertensive encephalopathy/PRES rather than attributing all symptoms to uremia. Persistent AMS, recurrent hypoglycemia, suspected CNS disease, sepsis, significant toxicity or an urgent dialysis indication usually requires admission with monitoring matched to severity. Transfer early when dialysis, critical care or neurological services are unavailable.
Handover: baseline and trend, last known well, last dialysis and events during it, access, anticoagulants and suspect drugs, results, treatment response, pending tests and the agreed dialysis/correction plan.
